Lovenox 150 mg/mL (Enoxaparin Sodium INJECTION) 150 mg/mL

Lovenox 150 mg/mL is a subcutaneous injection containing enoxaparin sodium, used for blood thinning and preventing clots. This medication is commonly prescribed for various conditions requiring anticoagulation therapy.

Strength

150 mg/mL

Pack Size

10 CELLO PACK in 1 CARTON (0075-2915-01) / 1 SYRINGE in 1 CELLO PACK (0075-2915-00) / 1 mL in 1 SY

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lovenox 150 mg/mL is primarily used for preventing and treating blood clots. It is often prescribed for conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). This medication may also be used during certain medical procedures to prevent clot formation. What is Lovenox used for? It is typically used for anticoagulation therapy to manage or prevent blood clots in various medical scenarios.

Side Effects

Common effects of Lovenox 150 mg/mL may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions, though these are less frequent. It is important to monitor for any unusual bleeding or signs of allergic reactions while using this medication.

Precautions & Warnings

Lovenox 150 mg/mL should be handled with care to avoid contamination. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the medication as directed, typically at room temperature, and avoid freezing. Always check the syringe for any particles or discoloration before use.

Avoid Interactions

Lovenox 150 mg/mL may interact with other medications that affect blood clotting, such as aspirin, warfarin, or nonsteroidal anti-inflammatory drugs (NSAIDs). It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Lovenox 150 mg/mL is used for preventing and treating blood clots, often in conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE).

Lovenox 150 mg/mL is administered via subcutaneous injection, typically into the abdomen or thigh. Follow the instructions provided by your healthcare professional.

Common side effects may include bruising, bleeding, and pain at the injection site. Allergic reactions are less frequent but possible.

Lovenox 150 mg/mL may interact with other blood-thinning medications. Always consult your healthcare provider before combining it with other drugs.

Store Lovenox 150 mg/mL at room temperature and avoid freezing. Keep it away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.